Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index	Confusion, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder	Not yet recruiting	Phase 4	2026-02-27		NCT07428681

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Basel, Switzerland	243

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials